Business Description
Inari Medical Inc
NAICS : 334510
SIC : 3845
ISIN : US45332Y1091
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.31 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -1.67 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 6.95 | |||||
Beneish M-Score | 8.44 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 47.5 | |||||
3-Year EBITDA Growth Rate | -5.5 | |||||
3-Year Book Growth Rate | 25.6 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 19.01 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.02 | |||||
9-Day RSI | 47.69 | |||||
14-Day RSI | 43.68 | |||||
6-1 Month Momentum % | 12.24 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.8 | |||||
Quick Ratio | 1.45 | |||||
Cash Ratio | 0.79 | |||||
Days Inventory | 224.2 | |||||
Days Sales Outstanding | 47.95 | |||||
Days Payable | 58.41 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.5 | |||||
Shareholder Yield % | -0.37 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 87.15 | |||||
Operating Margin % | -5.66 | |||||
Net Margin % | -10.42 | |||||
FCF Margin % | 3.12 | |||||
ROE % | -12.83 | |||||
ROA % | -9.25 | |||||
ROIC % | -15.24 | |||||
3-Year ROIIC % | -2.9 | |||||
ROC (Joel Greenblatt) % | -31.8 | |||||
ROCE % | -6.55 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 197.03 | |||||
PS Ratio | 4.78 | |||||
PB Ratio | 6.19 | |||||
Price-to-Tangible-Book | 34.31 | |||||
Price-to-Free-Cash-Flow | 155.45 | |||||
Price-to-Operating-Cash-Flow | 95.91 | |||||
EV-to-EBIT | -73.23 | |||||
EV-to-EBITDA | -128.46 | |||||
EV-to-Revenue | 4.66 | |||||
EV-to-Forward-Revenue | 3.58 | |||||
EV-to-FCF | 150.83 | |||||
Earnings Yield (Greenblatt) % | -1.37 | |||||
FCF Yield % | 0.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Inari Medical Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 506.74 | ||
EPS (TTM) (€) | -0.914 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 43.68 | ||
14-Day ATR (€) | 1.106158 | ||
20-Day SMA (€) | 40.19 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 34.2 - 59.5 | ||
Shares Outstanding (Mil) | 58.27 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Inari Medical Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Inari Medical Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Inari Medical Inc Frequently Asked Questions
What is Inari Medical Inc(FRA:IM7)'s stock price today?
When is next earnings date of Inari Medical Inc(FRA:IM7)?
Does Inari Medical Inc(FRA:IM7) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |